Dissociative Agents: Phencyclidine, Ketamine and Dextromethorphan

Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition

Volumn , Issue , 2007, Pages 773-779

  Liang, Ivan E ^a,b   Boyer, Edward W ^c,d,e,f  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877985340     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0693-4.50048-7     Document Type: Chapter

References (62)

1. T Litovitz, W Klein-Schwartz and E Caravati (2003) 2002 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 22 517-575.
2. W Watson (2003) TESS Dextromethorphan Data Washington, DC: American Association of Poison Control Centers
3. EW Boyer (2003) 2003 Poisoning Data Boston: Massachusetts Poison Control Center
4. Anonymous (2003) Trouble in the medicine chest (I): Rx drug abuse growing. Prevention Alert 6.
5. E Boyer, L Quang, A Woolf, M Shannon and B Magnani (2001) Dextromethorphan and ecstasy pills. JAMA 285 409-410.
6. M Baggott, B Heifets, R Jones, J Mendelson, et al. (2000) Chemical analysis of ecstasy pills. JAMA 284 2190.
7. EW Boyer and AW Woolf (2000) What's new on the street. Clin Pediatr Emerg Med 1 12-15.
8. R Kohrs and M Durieux (1998) Ketamine: teaching an old drug new tricks. Anesth Analg 87 1186-1193.
9. N Lindefors, S Barati and W O'Connor (1997) Differential effects of single and repeated ketamine administration on dopamine, serotonin, and GABA transmission in rat medial prefrontal cortex. Brain Res 759 205.
10. S Pradhan (1984) Phencyclidine (PCP): some human studies. Neurosci Behav Physiol 8 493-501.
11. G Lundberg, R Gupta and M Montgomery (1976) Phencyclidine (PCP): patterns seen in street drug analysis. J Toxicol Clin Toxicol 9 503-510.
12. J Rainey and M Crowder (1974) Prevalence of phencyclidine in street drug preparations. N Engl J Med 290 466-467.
13. D Bailey (1987) Phencyclidine detection during toxicology testing of a university medical patient population. J Toxicol Clin Toxicol 25 517-526.
14. M O'Brien (December 9–12, 2003) Emerging trends in drug use. Presented at the CEWG Annual Conference, Atlanta, GA Bethesda, MD: National Institute on Drug Abuse.
15. C Showalter and W Thornton (1977) Clinical pharmacology of phencyclidine toxicity. Am J Psychiatry 134 1234-1238.
16. A Misra, R Pontani and J Bartolomeo (1979) Persistence of phencyclidine and metabolites in brain and adipose tissue and implications for long-lasting behavioral effects. Res Commun Chem Pathol Pharmacol 24 431-435.
17. J Holland, L Nelson and P Ravikumar (1998) Embalming-fluid soaked marijuana: a new high or new guise for PCP? J Psychoactive Drugs 30 215-219.
18. C Cook, D Brine and G Quin (1982) Phencyclidine and phenylcyclohexane disposition after smoking phencyclidine. Clin Pharmacol Ther 31 635-641.
19. G Simpson and A Khajawall (1982) Urinary phencyclidine excretion in chronic abusers. J Toxicol Clin Toxicol 19 1051-1059.
20. C Liden and F Lovejoy (1975) Phencyclidine: nine cases of poisoning. JAMA 234 513-516.
21. M McCarron, B Schulze and G Thompson (1981) Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 10 290-297.
22. M McCarron, B Schulze and G Thompson (1981) Acute phencyclidine intoxication: incidence of clinical findings in 1000 cases. Ann Emerg Med 10 232-242.
23. R Burns and S Lerner (1976) Perspectives: acute phencyclidine intoxication. Clin Toxicol 9 477-501.
24. S Heilig, J Diller and F Nelson (1982) A study of 44 PCP related deaths. Int J Addiction 17 1175-1184.
25. R Balster (1986) Clinical implications of behavioral pharmacology research on phencyclidine. NIDA Res Monogr 64 148-162.
26. R Rawson, F Tennant and M McCann (1981) Characteristics of 68 chronic phencyclidine users who sought treatment. Drug Alcohol Depend 8 223-227.
27. J Hick, S Smith and M Lynch (1999) Metabolic acidosis in restraint-associated cardiac arrest: a case series. Acad Emerg Med 6 239-245.
28. P White (1982) Ketamine: its pharmacology and therapeutic uses. Anesthesiology 56 119-136.
29. R Baselt and R Cravey (1989) Disposition of Toxic Drugs and Chemicals in Man Chicago: Yearbook Medical Publishers
30. D Reich and G Silvay (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36 186-197.
31. Y Hajazi and R Boulieu (2002) Protein binding of ketamine and its active metabolites to human serum. Eur J Clin Pharmacol 58 37-40.
32. I Grant, W Nimmo and J Clements (1981) Pharmacokinetics and analgesic effects of intramuscular and oral ketamine. Br J Anaesth 53 805-810.
33. I Grant, W Nimmo and J Clements (1983) Ketamine disposition in children and adults. Br J Anaesth 55 1107-1111.
34. A Weiner, L Vieira, C McKay and M Bayer (2000) Ketamine abusers presenting to the emergency department: a case series. J Emerg Med 18 447-451.
35. S Green and J Li (2000) Ketamine in adults: what emergency physicians need to know about patient selection and emergence reactions. Acad Emerg Med 7 278-281.
36. M Shannon (1998) Recent ketamine administration can produce urine toxic screen which is falsely positive for phencyclidine. Pediatr Emerg Care 14 180.
37. EW Boyer (2004) Dextromethorphan abuse. Pediatr Emerg Care 20 858-863.
38. T Kirages, H Sule and M Mycyk (2003) Severe manifestations of coricidin intoxication. Am J Emerg Med 21 648-651.
39. J Barnhart and E Massad (1979) Determination of dextromethorphan in serum by gas chromatography. J Chromatogr 163 390-395.
40. M Silvasti, P Karttunen and H Tukiannen (1987) Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther 9 493-497.
41. M Schadel, D Wu, S Otton, et al. (1995) Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol 15 263-269.
42. White W: DXM FAQ. Vol. 2004: Erowid, www.erowid.org, 1995.
43. Anonymous: RFG's guide to DXM (dextromethorphan). Vol. 2004: DXM Harm Reduction Project, www.dextromethorphan.ws, 2004.
44. S Banerji and I Anderson (2001) Abuse of Coricidin HBP Cough & Cold: episodes recorded by a poison center. Am J Health System Pharmacy 58 1811-1814.
45. A Graudins and R Ferm (1996) Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan-containing cough and cold syrup. J Toxicol Clin Toxicol 34 351-352.
46. A Hinsberger and V Sharma (1994) Cognitive deterioration from long-term abuse of dextromethorphan: a case report. J Psychiatry Neurosci 19 375-377.
47. P Fleming (1986) Dependence on dextromethorphan. BMJ 293 597.
48. T Wolfe and E Caravati (1995) Massive dextromethorphan ingestion and abuse. Am J Emerg Med 13 174-176.
49. K Nicholson, B Hayes and R Balster (1999) Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rates and rhesus monkeys. Psychopharmacology 146 49-59.
50. A Dodds (1967) Toxic psychosis due to dextromethorphan. Med J Aust 2 231.
51. M Schadel and E Sellers (1992) Psychosis with Vicks Formula 44-D abuse. Can Med Assoc J 147 843-844.
52. J Helfer and O Kim (1990) Psychoactive abuse potential of Robitussin-DM. Am J Psychiatry 147 672-673.
53. Y Ng, W Lin, T Chen and S Tsai (1992) Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol 12 268-270.
54. T Bowdle (1998) Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf 19 173-189.
55. M Shannon (2000) Methylenedioxymethamphetamine. Pediatr Emerg Care 16 377-380.
56. D Baker and D Borys (2000) Coricidin use and abuse in Texas during 1998 and 1999. J Toxicol Clin Toxicol 38 533.
57. Anonymous (December 9–12, 2003) Group discussion: pharmaceutical abuse. Presented at the CEWG Annual Conference, Atlanta, GA Bethesda, MD: National Institute on Drug Abuse
58. S Cutler (December 9–12, 2003) Philadelphia report. Presented at the CEWG Annual Conference, Atlanta, GA Bethesda, MD: National Institute on Drug Abuse
59. Dooley D: Boston report. Presented at the CEWG Annual Meeting, Atlanta, GA, December 9–12, 2003. Bethesda, MD: National Institute on Drug Abuse.
60. M Darboe, G Keenan and T Richards (1996) The abuse of dextromethorphan: a pilot study of the community of Waynesboro, PA. Adolescence 31 633-644.
61. J Schier and J Diaz (2000) Avoid unfavorable consequences: dextromethorphan can bring about a false-positive phencyclidine urine drug screen. J Emerg Med 18 379-380.
62. F Henretig, D Cugini and D Dubin (1988) Dextromethorphan overdose in children. Vet Hum Toxicol 3 364.